Torrid Holdings Inc. Q4 '25 results miss: comps -10%, margins down 360 bps; FY26 sales to fall. Click for this updated look ...
Retatrutide, an experimental diabetes drug, reduced A1C levels by 2 percent and body weight by 17 percent in a new late-stage ...
Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...
FDA approval establishes setmelanotide as the first labeled option for acquired hypothalamic obesity, addressing a population ...
The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...
A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost ...
The Danish drugmaker said the accelerated approval was based on results from its Step Up trial, which showed 20.7% mean ...
It's 'definitely not a measure of fatness,' and it doesn't accurately define what it means to be overweight. Body mass index ...
Morning Overview on MSN
Study links Wegovy to nearly 5x higher sudden sight-loss risk vs Ozempic
A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of a sudden, sight-threatening eye condition compared with those on Ozempic, ...
A commentary by Calvin Meaney urges discontinuation of outdated tests that are imprecise or disadvantage Black patients.
The Council Bluffs Fire Department has partnered with OneDose to calculate medication doses, helping paramedics deliver faster and more accurate care ...
After the U.S. transplant system ended use of the race-based test, it ordered hospitals to determine which Black patients on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results